Literature DB >> 21195980

Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.

Amir Houshang Mohammad Alizadeh1, Mitra Ranjbar, Ali Shabahang Saber Tehrani, Fariba Keramat, Moggan Mamani, Mehdi Rezazadeh, Peyman Aini, Alireza Khalilian, Amir Majlesi, Mehrdad Hajilooi.   

Abstract

Despite the decreasing trend in hepatitis D virus (HDV) infection worldwide, the importance of this disease cannot be underestimated. The aim of this study was to evaluate patients positive for HBsAg with respect to HDV infection and related factors. Patients with chronic hepatitis B who presented at Hamedan Province Hepatitis Community Center in 2002-2007 were included. A questionnaire covering demographic variables and history of hepatic disease was completed for each patient. Necessary tests were performed and antibodies to HDV were measured using an enzyme-linked immunosorbent assay. Of 81 HBsAg positive patients, 14 (17.3%) contained anti-HDV IgG. Only one of the patients with anti-HDV IgM was positive for HBsAg. Of the anti-HDV IgG positive patients, two (14.3%) were women. Among the women examined in this study, 24 (35.8%) were anti-HDV IgG negative (p = 0.21), and of these, six (42.8%) were HBeAg positive while 17 (25.4%) of the anti-HDV IgG negative women were positive for HBeAg (p = 0.16). The prevalence of chronic hepatitis B among anti-HDV IgG positive and negative patients was 28.6% and 39.2% respectively (p = 0.31). Because of the relatively high rate of hepatitis B virus (HBV) and HDV co-infection in our study subjects, it is vital that healthcare providers and policy makers to recognize the risk factors associated with this HBV and HDV co-infection as well as the reasons for this increased anti-HDV serology in HBV carriers. Copyright Â
© 2010 Taiwan Society of Microbiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195980     DOI: 10.1016/S1684-1182(10)60080-1

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  Hepatitis delta: on soft paws across Germany.

Authors:  C Reinheimer; H W Doerr; A Berger
Journal:  Infection       Date:  2012-07-01       Impact factor: 3.553

2.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

3.  Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Yaser Saiedi Hosseini; Seyed Hossein Aalaei Andabili
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

4.  Prevalence of hepatitis d virus infection among patients with chronic hepatitis B attending birjand hepatitis clinic (East of iran) in 2012.

Authors:  Masood Ziaee; Ghodsieh Azarkar
Journal:  Hepat Mon       Date:  2013-08-25       Impact factor: 0.660

5.  Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections.

Authors:  Babak Sayad; Yosra Naderi; Seyed Moayed Alavian; Farid Najafi; Alireza Janbakhsh; Feyzollah Mansouri; Siavash Vaziri; Mandana Afsharian; Fatemeh Norooznezhad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

6.  Histological and Serological Epidemiology of Hepatitis Delta Virus Coinfection among Patients with Chronic Active Hepatitis B Virus in Razavi Khorasan Province, Northeastern Iran.

Authors:  Payam Sharifan; Sakineh Amoueian
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

7.  Prevalence of hepatitis D virus among HBsAg-positive individuals, 2015-2016: Azar cohort study.

Authors:  Ali Asghar Pouri; Morteza Ghojazadeh; Babak Baiaz; Fatemeh Soghra Hamzavi; Behrouz Pourasghari; Mohammad Hossein Somi
Journal:  Health Promot Perspect       Date:  2020-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.